Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY21 results · Jul–Sep 2020
Max Healthcare Institute reported revenue from operations of ₹650.94 crore and net profit of ₹13.11 crore for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 650.94 | — | — | — | — |
| Other income | 40.32 | — | — | — | — |
| Total income | 691.26 | — | — | — | — |
| Profit before tax | 17.43 | — | — | — | — |
| Net profit for the period | 13.11 | — | — | — | — |
| EPS, basic (₹) | 0.16 | — | — | — | — |
| Net margin (%) | 2.0 | — | — |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 281.93 | — | — | — | — |
| Other income | 31.47 | — | — | — | — |
| Total income | 313.40 | — | — | — | — |
| Profit before tax | 10.26 | — | — | — | — |
| Net profit for the period | 10.43 | — | — | — | — |
| EPS, basic (₹) | 0.12 | — | — | — | — |
| Net margin (%) | 3.7 | — | — |
Consolidated
- Filed with BSE
- 16 Nov 2020, 15:31 IST
- Board meeting
- 11 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 Nov 2020, 15:31 IST
- Board meeting
- 11 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE